Davis Polk today announced that leading trial lawyer John (Jay) Neukom has joined the firm as a partner in the IP Litigation ...
First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...
DLA Piper has welcomed Josh Seidenfeld as Chair of the firm’s Northern California Corporate and Securities practice. Based in ...
Redefining hydrophilic coatings solutions by uniting advanced chemistry, device engineering and customer-first ...
OXNARD, CA / ACCESS Newswire / February 2, 2026 / Quality Dental Services functions as a foundational component supplier ...
Global Healthcare Asset Management Market OutlookThe global healthcare asset management market is poised for remarkable ...
Global Medical Adhesive Tapes Market OverviewThe global medical adhesive tapes market is anticipated to grow at a CAGR of approximately 6% during the forecast period, supported by a combination of ...
Critical Manufacturing, a leading provider of next-generation Manufacturing Execution Systems (MES) and a subsidiary of ASMPT, today announced a major appointment. Paul Straeten, a digital ...
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Newly created spin-off of Gustave Roussy and SATT Paris-Saclay specializing in immuno-oncology will exploit hidden genome, also known as dark genome or non-coding genomeIt intends to develop a first ...
Partnership expands education, visibility and leadership around sustainable lab practices DAYTON, OHIO / ACCESS Newswire / February 2, 2026 / The Society for Laboratory Automation and Screening (SLAS) ...
Humanetics presentation will showcase advancements in BIOGRAYZ™ (BIO 300) development, an orally administered prophylactic ...
TrialRelay™, powered by the TrialRouter™ AI agent, replaces passive networks with active orchestration for physician-to-physician handoffs.ORLANDO, Fla.--(BUSINESS WIRE)--Massive Bio today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results